Structural and functional characteristics of S1P receptors

Journal of Cellular Biochemistry

Volumn 92, Issue 5, 2004, Pages 913-922

  Sanchez, Teresa ^a   Hla, Timothy ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Migration; Rho GTPases; Sphingosine kinase; Vascular maturation; Vascular permeability

Indexed keywords

FINGOLIMOD; G PROTEIN COUPLED RECEPTOR; SPHINGOMYELIN; SPHINGOSINE 1 PHOSPHATE RECEPTOR;

BLOOD VESSEL PERMEABILITY; CANCER INHIBITION; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CYTOSKELETON; DRUG ACTIVITY; HEART DEVELOPMENT; HUMAN; LYMPHOCYTE; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; ANIMAL; CHEMISTRY; GENETICS; MOLECULAR CLONING; PHYLOGENY; PHYSIOLOGY; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION;

ANIMALS; CLONING, MOLECULAR; HUMANS; PHYLOGENY; PROTEIN CONFORMATION; RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION;

EID: 12544253058     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20127     Document Type: Review

References (70)

1. Allende ML, Yamashita T, Proia RL. 2003. G-protein coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation. Blood 102:3665-3667.
2. Ancellin N, Hla T. 1999. Differential pharmacological, properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5. J Biol Chem 274:18997-19002.
3. Aranda JM, Jr., Hill J. 2000. Cardiac transplant vasculopathy. Chest 118:1792-1800.
4. Arikawa K, Takuwa N, Yamaguchi H, Sugimoto N, Kitayama J, Nagawa H, Takehara K, Takuwa Y. 2003. Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity. J Biol Chem 278:32841-32851.
5. Billich A, Bornancin F, Devay P, Mechtcheriakova D, Urtz N, Baumruker T. 2003. Phosphorylation of the imunomodulatory drug FTY720 by sphingosine kinases. J Biol Chem 278:47408-47415.
6. Bornfeldt KE, Graves LM, Raines EW, Igarashi Y, Wayman G, Yamamura S, Yatomi Y, Sidhu JS, Krebs EG, Hakomori S, et al. 1995. Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: Spatial and temporal modulation of PDGF chemotactic signal transduction. J Cell Biol 130:193-206.
7. Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, Hof R, Bruns C, Prieschl E, Baumruker T, Hiestand P, Foster CA, Zollinger M, Lynch KR. 2002. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 277:21453-21457.
8. Candelore MR, Wright MJ, Tota LM, Milligan J, Shei GJ, Bergstrom JD, Mandala SM. 2002. Phytosphingosine 1-phosphate: A high affinity ligand for the S1P(4)/EDG-6 receptor. Biochem Biophys Res Commun 297:600-606.
9. Chen S, Bacon KB, Garcia G, Liao R, Pan ZK, Sullivan SK, Nakano H, Matsuzawa A, Brinkmann V, Feng L. 2001. FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokines. Transplant Proc 33:3057-3063.
10. Clemens JJ, Davis MD, Lynch KR, Macdonald TL. 2003. Synthesis of para-alkyl aryl amide analogues of sphingosine-1-phosphate: Discovery of potent S1P receptor agonists. Bioorg Med Chem Lett 13:3401-3404.
11. 1 G protein-coupled receptor. J Immunol 171:3500-3507.
12. Ferrara N, Gerber HP, LeCouter J. 2003. The biology of VEGF and its receptors. Nat Med 9:669-676.
13. Glickman M, Malek RL, Kwitek-Black AE, Jacob HJ, Lee NH. 1999. Molecular cloning, tissue-specific expression, and chromosomal localization of a novel nerve growth factor-regulated G-protein-coupled receptor, nrg-1. Mol Cell Neurosci 14:141-152.
14. Graeler M, Goetzl EJ. 2002. Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells. Faseb J 16: 1874-1878.
15. Graeler M, Shankar G, Goetzl EJ. 2002. Cutting edge: Suppression of T cell chemotaxis by sphingosine 1-phosphate. J Immunol 169:4084-4087.
16. Graler MH, Bernhardt G, Lipp M. 1998. EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue. Genomics 53:164-169.
17. Hall A. 1998. Rho GTPases and the actin cytoskeleton. Science 279:509-514.
18. Hla T, Maciag T. 1990. An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J Biol Chem 265:9308-9313.
19. Igarashi J, Bernier SG, Michel T. 2001. Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells. J Biol Chem 276:12420-12426.
20. Im DS, Heise CE, Ancellin N, O'Dowd BF, Shei GJ, Heavens RP, Rigby MR, Hla T, Mandala S, McAllister G, George SR, Lynch KR. 2000. Characterization of a novel sphingosine 1-phosphate receptor, EDG-8. J Biol Chem 275:14281-14286.
21. Ishii I, Friedman B, Ye X, Kawamura S, McGiffert C, Contos JJ, Kingsbury MA, Zhang G, Brown JH, Chun J. 2001. Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3. J Biol Chem 276:33697-33704.
22. Ishii I, Ye X, Friedman B, Kawamura S, Contos JJ, Kingsbury MA, Yang AH, Zhang G, Brown JH, Chun J. 2002. Marked perinatal lethality and cellular signaling deficits in mice null for the two sphingosine 1-phosphate (S1P) receptors, S1P(2)/LP(B2)/EDG-5 and S1P(3)/ LP(B3)/EDG-3. J Biol Chem 277:25152-25159.
23. Kluk MJ, Hla T. 2001. Role of the sphingosine 1-phosphate receptor EDG-1 in vascular smooth muscle cell proliferation and migration. Circ Res 89:496-502.
24. Kluk MJ, Hla T. 2002. Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. Biochim Biophys Acta 1582:72-80.
25. Kohno T, Matsuyuki H, Inagaki Y, Igarashi Y. 2003. Sphingosine 1-phosphate promotes cell migration through the activation of Cdc42 in EDG-6/S1P4-expressing cells. Genes Cells 8:685-697.
26. Kupperman E, An S, Osborne N, Waldron S, Stainier DY. 2000. A sphingosine-1-phosphate receptor regulates cell migration during vertebrate heart development. Nature 406:192-195.
27. Lee MJ, Evans M, Hla T. 1996. The inducible G protein-coupled receptor edg-1 signals via the G(i)/mitogen-activated protein kinase pathway. J Biol Chem 271: 11272-11279.
28. Lee MJ, Thangada S, Liu CH, Thompson BD, Hla T. 1998a. Lysophosphatidic acid stimulates the G-protein-coupled receptor EDG-1 as a low affinity agonist. J Biol Chem 273:22105-22112.
29. Lee MJ, Van Brooklyn JR, Thangada S, Liu CH, Hand AR, Menzeleev R, Spiegel S, Hla T. 1998b. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 279:1552-1555.
30. Lee MJ, Thangada S, Claffey KP, Ancellin N, Liu CH, Kluk M, Volpi M, Sha'afi RI, Hla T. 1999. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 99:301-312.
31. Lee MJ, Thangada S, Paik JH, Sapkota GP, Ancellin N, Chae SS, Wu M, Morales-Ruiz M, Sessa WC, Alessi DR, Hla T. 2001. Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis. Mol Cell 8:693-704.
32. Lim HS, Oh YS, Suh PG, Chung SK. 2003. Syntheses of sphingosine-1- phosphate stereoisomers and analogues and their interaction with EDG receptors. Bioorg Med Chem Lett 13:237-240.
33. Liu Y, Wada R, Yamashita T, Mi Y, Deng CX, Hobson JP, Rosenfeldt HM, Nava VE, Chae SS, Lee MJ, Liu CH, Hla T, Spiegel S, Proia RL. 2000. EDG-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest 106:951-961.
34. MacKinnon AC, Buckley A, Chilvers ER, Rossi AG, Haslett C, Sethi T. 2002. Sphingosine kinase: A point of convergence in the action of diverse neutrophil priming agents. J Immunol 169:6394-6400.
35. MacLennan AJ, Browe CS, Gaskin AA, Lado DC, Shaw G. 1994. Cloning and characterization of a putative G-protein coupled receptor potentially involved in development. Mol Cell Neurosci 5:201-209.
36. MacLennan AJ, Devlin BK, Marks L, Gaskin AA, Neitzel KL, Lee N. 2000. Antisense studies in PC12 cells suggest a role for H218, a sphingosine 1-phosphate receptor, in growth-factor-induced cell-cell interaction and neurite outgrowth. Dev Neurosci 22:283-295.
37. MacLennan AJ, Carney PR, Zhu WJ, Chaves AH, Garcia J, Grimes JR, Anderson KJ, Roper SN, Lee N. 2001. An essential role for the H218/AGR16/EDG-5/LP(B2) sphingosine 1-phosphate receptor in neuronal excitability. Eur J Neurosci 14:203-209.
38. Malek RL, Toman RE, Edsall LC, Wong S, Chiu J, Letterle CA, Van Brooklyn JR, Milstien S, Spiegel S, Lee NH. 2001. Nrg-1 belongs to the endothelial differentiation gene family of G protein-coupled sphingosine-1-phosphate receptors. J Biol Chem 276:5692-5699.
39. Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, Milligan J, Thornton R, Shei GJ, Card D, Keohane C, Rosenbach M, Hale J, Lynch CL, Rupprecht K, Parsons W, Rosen H. 2002. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296: 346-349.
40. Miller LW. 2002. Cardiovascular toxicities of immunosuppressive agents. Am J Transplant 2:807-818.
41. Morales-Ruiz M, Lee MJ, Zollner S, Gratton JP, Scotland R, Shiojima I, Walsh K, Hla T, Sessa WC. 2001. Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells. J Biol Chem 276: 19672-19677.
42. Morita Y, Perez GI, Paris F, Miranda SR, Ehleiter D, Haimovitz-Friedman A, Fuks Z, Xie Z, Reed JC, Schuchman EH, Kolesnick RN, Tilly JL. 2000. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med 6: 1109-1114.
43. Newby AC, Zaltsman AB. 2000. Molecular mechanisms in intimal hyperplasia. J Pathol 190:300-309.
44. 2+ mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition. J Biol Chem 273:27104-27110.
45. Okazaki H, Ishizaka N, Sakurai T, Kurokawa K, Goto K, Kumada M, Takuwa Y. 1993. Molecular cloning of a novel putative G protein-coupled receptor expressed in the cardiovascular system. Biochem Biophys Res Commun 190:1104-1109.
46. Olivera A, Spiegel S. 1993. Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature 365:557-560.
47. Paik JH, Chae S, Lee MJ, Thangada S, Hla T. 2001. Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins. J Biol Chem 276:11830-11837.
48. Parrill AL, Wang D, Bautista DL, Van Brocklyn JR, Lorincz Z, Fischer DJ, Baker DL, Liliom K, Spiegel S, Tigyi G. 2000. Identification of EDG1 receptor residues that recognize sphingosine 1-phosphate. J Biol Chem 275: 39379-39384.
49. Prieschl EE, Csonga R, Novotny V, Kikuchi GE, Baumruker T. 1999. The balance between sphingosine and sphingosine-1-phosphate is decisive for mast cell activation after Fc epsilon receptor I triggering. J Exp Med 190: 1-8.
50. Pyne S, Pyne N. 2000. Sphingosine 1-phosphate signalling via the endothelial differentiation gene family of G-protein-coupled receptors. Pharmacol Ther 88:115-131.
51. Ryu Y, Takuwa N, Sugimoto N, Sakurada S, Usui S, Okamoto H, Matsui O, Takuwa Y. 2002. Sphingosine-1-phosphate, a platelet-derived lysophospholipid mediator, negatively regulates cellular Rac activity and cell migration in vascular smooth muscle cells. Circ Res 90: 325-332.
52. Sadahira Y, Ruan F, Hakomori S, Igarashi Y. 1992. Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness. Proc Natl Acad Sci USA 89:9686-9690.
53. Sanchez T, Estrada-Hernandez T, Paik JH, Wu MT, Venkataraman K, Brinkmann V, Claffey K, Hla T. 2003. Phosphorylation and action of the immunomodulator FTY720 inhibits VEGF-induced vascular permeability. J Biol Chem 278:47281-47290.
54. Schwartz SM, deBlois D, O'Brien ER. 1995. The intima: Soil for atherosclerosis and restenosis. Circ Res 77:445-465.
55. Sugimoto N, Takuwa N, Okamoto H, Sakurada S, Takuwa Y. 2003. Inhibitory and stimulatory regulation of Rac and cell motility by the G12/13-Rho and Gi pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform. Mol Cell Biol 23: 1534-1545.
56. Sukocheva OA, Wang L, Albanese N, Pitson SM, Vadas MA, Xia P. 2003. Sphingosine kinase transmits estrogen signaling in human breast cancer cells. Mol Endocrinol 17:2002-2012.
57. Tovbin D, Feldman L, Basok A, Shnaider A, Hertzanu Y, Lantsberg S, Mostoslavsky M, Zlotnik M. 2000. Renal transplant dysfunction due to severe aorto-iliac atherosclerosis in the presence of patent renal transplant artery. Am J Nephrol 20:487-490.
58. Uretsky BF, Kormos RL, Zerbe TR, Lee A, Tokarczyk TR, Murali S, Reddy PS, Denys BG, Griffith BP, Hardesty RL, et al. 1992. Cardiac events after heart transplantation: Incidence and predictive value of coronary arteriography. J Heart Lung Transplant 11:S45-S51.
59. Van Brocklyn JR, Lee MJ, Menzeleev R, Olivera A, Edsall L, Cuvillier O, Thomas DM, Coopman PJ, Thangada S, Liu CH, Hla T, Spiegel S. 1998. Dual actions of sphingosine-1-phosphate: Extracellular through the Gi-coupled receptor EDG-1 and intracellular to regulate proliferation and survival. J Cell Biol 142:229-240.
60. Van Brocklyn JR, Tu Z, Edsall LC, Schmidt RR, Spiegel S. 1999. Sphingosine 1-phosphate-induced cell rounding and neurite retraction are mediated by the G protein-coupled receptor H218. J Biol Chem 274:4626-4632.
61. Van Brocklyn JR, Graler MH, Bernhardt G, Hobson JP, Lipp M, Spiegel S. 2000. Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6. Blood 95:2624-2629.
62. Van Brocklyn JR, Young N, Roof R. 2003. Sphingosine-1-phosphate stimulates motility and invasiveness of human glioblastoma multiforme cells. Cancer Lett 199: 53-60.
63. Windh RT, Lee MJ, Hla T, An S, Barr AJ, Manning DR. 1999. Differential coupling of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and H218/EDG-5 to the G(i), G(q), and G(12) families of heterotrimeric G proteins. J Biol Chem 274:27351-27358.
64. Xia P, Wang L, Gamble JR, Vadas MA. 1999. Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells. J Biol Chem 274:34499-35505.
65. Yamaguchi F, Tokuda M, Hatase O, Brenner S. 1996. Molecular cloning of the novel human G protein-coupled receptor (GPCR) gene mapped on chromosome 9. Biochem Biophys Res Commun 227:608-614.
66. Yamaguchi H, Kitayama J, Takuwa N, Arikawa K, Inoki I, Takehara K, Nagawa H, Takuwa Y. 2003. Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells. Biochem J 374: 715-722.
67. (2+) signaling pathway. Biochem Biophys Res Commun 268:583-589.
68. Yatomi Y, Igarashi Y, Yang L, Hisano N, Qi R, Asazuma N, Satoh K, Ozaki Y, Kume S. 1997. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem (Tokyo) 121:969-973.
69. Zhang H, Desai NN, Olivera A, Seki T, Brooker G, Spiegel S. 1991. Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J Cell Biol 114:155-167.
70. Zohlnhofer D, Richter T, Neumann F, Nuhrenberg T, Wessely R, Brandl R, Murr A, Klein CA, Baeuerle PA. 2001. Transcriptome analysis reveals a role of interferon-gamma in human neointima formation. Mol Cell 7:1059-1069.